These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 33912936

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.
    Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Imazeki I, Kusano E, Shigematsu T, Akizawa T.
    Nephrol Dial Transplant; 2008 May; 23(5):1529-36. PubMed ID: 18156462
    [Abstract] [Full Text] [Related]

  • 23. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E, Finch J, Ritter C, Takahashi F.
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [Abstract] [Full Text] [Related]

  • 24. Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
    Miller G, Davis J, Shatzen E, Colloton M, Martin D, Henley CM.
    Nephrol Dial Transplant; 2012 Jun; 27(6):2198-205. PubMed ID: 22036941
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.
    Naveh-Many T, Volovelsky O.
    Int J Mol Sci; 2020 Jun 18; 21(12):. PubMed ID: 32570711
    [Abstract] [Full Text] [Related]

  • 28. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H.
    Kidney Int; 2002 Oct 18; 62(4):1196-207. PubMed ID: 12234290
    [Abstract] [Full Text] [Related]

  • 29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 18; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 30. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H, Iida M.
    Nephrol Dial Transplant; 2003 Jun 18; 18 Suppl 3():iii9-12. PubMed ID: 12771291
    [Abstract] [Full Text] [Related]

  • 31. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S, Farnebo F, Forsberg L, Larsson C, Farnebo LO.
    Kidney Int; 2001 Nov 18; 60(5):1666-75. PubMed ID: 11703583
    [Abstract] [Full Text] [Related]

  • 32. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
    Indridason OS, Heath H, Khosla S, Yohay DA, Quarles LD.
    Kidney Int; 1996 Nov 18; 50(5):1663-71. PubMed ID: 8914034
    [Abstract] [Full Text] [Related]

  • 33. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
    Latus J, Lehmann R, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W, Biegger D, Ott G, Dippon J, Alscher MD, Kimmel M.
    Kidney Blood Press Res; 2013 Nov 18; 37(1):84-94. PubMed ID: 23552627
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of increased parathyroid hormone mRNA in experimental uremia: roles of protein RNA binding and RNA degradation.
    Yalcindag C, Silver J, Naveh-Many T.
    J Am Soc Nephrol; 1999 Dec 18; 10(12):2562-8. PubMed ID: 10589695
    [Abstract] [Full Text] [Related]

  • 35. High sodium promotes the secretion and synthesis of PTH through PiT-1-IKKβ pathway in parathyroid gland in vitro.
    Shen A, Wang Y, Ye G, Mao J, Zhang Q, Chen J.
    Clin Sci (Lond); 2023 Jun 28; 137(12):947-962. PubMed ID: 37337945
    [Abstract] [Full Text] [Related]

  • 36. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T, Rastad J, Szabó E, Westin G, Akerström G.
    J Clin Endocrinol Metab; 2000 May 28; 85(5):2000-3. PubMed ID: 10843188
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Integrated transcriptomic and proteomic analyses for the characterization of parathyroid oxyphil cells in uremic patients.
    Mao J, You H, Wang M, Ni L, Zhang Q, Zhang M, Chen J.
    Amino Acids; 2022 May 28; 54(5):749-763. PubMed ID: 35348903
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.